Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Leash Biosciences
Leash Biosciences builds experimental datasets and machine learning models to accelerate discovery of novel small-molecule medicines. The company generates high-quality, purpose-built experimental…
Leash Biosciences
Leash Biosciences builds experimental datasets and machine learning models to accelerate discovery of novel small-molecule medicines. The company generates high-quality, purpose-built experimental…
TL;DR
What they do: Build experimental datasets and ML models to accelerate small‑molecule drug discovery for biotech and pharma (B2B)
Headquarters: Salt Lake City, Utah, United States
Stage: Seed
Founders: Ian Quigley (Co‑founder, CEO) and Andrew Blevins (Co‑founder, CTO)
Reported seed raise: $9.3M (seed, per company profiles)
Company Overview
Problem Domain
Medicinal chemistry and small‑molecule drug discovery (lead identification)
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
$9.3M
Reported seed round with multiple investors including Mitsui Global Investment, Metaplanet, Top Harvest Capital; Crunchbase/Dealroom profiles list seven investors.
Investor Signal
“Backed by institutional investors including SpringTide Ventures, Mitsui Global Investment, Metaplanet and Top Harvest Capital”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week